4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001140361-25-001188
Director bought 16,845,010 shares at $20.00 ($336,900,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. Director | 2025-01-13 | Purchase | +16,845,010 | $20.00 | $336,900,200 | 96,650,341 | D |
| Open-market purchases · 16,845,010 sh · avg $20.00 · $336,900,200 | |||||||
Loading xslF345X05/form4.xml…